Kotryna Seip

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells

Anna Barkovskaya, Kotryna Seip, Lina Prasmickaite et al. · Scientific Reports · 2020 · 54 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

AXL inhibition improves BRAF-targeted treatment in melanoma

Marta Nyakas, Karianne G. Fleten, Mads H. Haugen et al. · Scientific Reports · 2022 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

Kotryna Seip, Karianne G. Fleten, Anna Barkovskaya et al. · Oncotarget · 2016 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +17

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes

Anna Barkovskaya, Kotryna Seip, Bylgja Hilmarsdóttir et al. · Scientific Reports · 2019 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy

Eivind Valen Egeland, Kotryna Seip, Eleni Skourti et al. · British Journal of Cancer · 2024 · 11 citations · Full text

Medicine, Cancer Biology, Oncology +17